# Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL

> **NCT01358747** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon**

## Conditions studied

- Hodgkin's Lymphoma

## Interventions

- **DRUG:** BEACOPPesc
- **DRUG:** BEACOPPesc - ABVD - PET2

## Key facts

- **NCT ID:** NCT01358747
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358747, "Study of a Treatment Driven by Early PET Response to a Treatment Not Monitored by Early PET in Patients With AA Stage 3-4 or 2B HL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01358747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*